Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill to increase federal funding and research for chronic pain conditions and treatments.
The problem
Chronic pain affects millions of Americans. Current research funding may be insufficient to develop better treatments and understand pain conditions.
The proposal
The bill likely increases federal research funding for chronic pain studies, supports pain research initiatives, and may expand treatment options and education.
The impact
Patients with chronic pain, researchers, healthcare providers, and pharmaceutical companies developing pain treatments are affected by research funding changes.
More research funding could lead to new and better ways to treat chronic pain. This could help millions of people suffering from conditions like arthritis and back pain.
Increased funding creates jobs for scientists, researchers, and medical professionals. These are stable, well-paying jobs that support communities.
Better pain treatments could reduce reliance on opioid medications. This helps address addiction and overdose problems in the country.
New treatments allow people with chronic pain to work, exercise, and enjoy life more. This increases productivity and well-being across society.
The bill requires federal money to fund research. This adds to government spending and the national budget, which concerns some taxpayers.
More research funding does not guarantee new treatments will be found. Money spent may not produce practical solutions for patients.
Research benefits may reach wealthy areas first. Rural and poor communities might not have access to new treatments for many years.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.